NEWS & EVENTS

Through timely company announcements, media releases, events and presentations, Genmab discloses and informs all our stakeholders of key events throughout the year.

News Release Details

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Jan 4, 2022 at 12:38 AM CET
Supporting Materials:

Company Announcement

COPENHAGEN, Denmark; January 4, 2022 Genmab A/S (Nasdaq: GMAB) In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) made by managerial employees and their closely associated persons.

The company’s managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf to publish trading in Genmab shares by the company’s managerial employees and their closely associated persons.

This company announcement includes the partial vesting and net settlement of the restricted stock units granted to Jan van de Winkel and Judith Klimovsky on December 10, 2018. The remaining part of these two grants is subject to an additional vesting criteria and will vest upon confirmation thereof.

 

CVR no. 2102 3884
LEI Code 529900MTJPDPE4MHJ122

Genmab A/S
Kalvebod Brygge 43
1560 Copenhagen V
Denmark

Attachment

You are now leaving Genmab.com to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.